Clinical Trials Browser

2'-((4'-trifluoromethanesulfonyloxy)phenyl)-N-methanesulfonylpropionamide × 90 days × Clear all

NCT05815173 2025-12-30

Ladarixin With Sotorasib in Advanced NSCLC

Phase 1 Recruiting

Advanced Non-small Cell Lung Cancer With KRAS G12C Mutation